European Directorate for the Quality of Medicines & Health Care (EDQM) has granted a Certificate of Suitability for IOL Chemicals & Pharmaceuticals Ltd's API product "MINOXIDIL" on 4th December 2025. Minoxidil is primarily used as a topical treatment for hereditary hair loss.